You have 9 free searches left this month | for more free features.

selective serotonin reuptake inhibitor (SSRI)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Major Depressive Disorder With Anhedonia and Inadequate Response

Not yet recruiting
  • Depressive Disorder, Major
  • No Intervention
  • (no location specified)
Apr 24, 2023

Haemorrhage Between Vortioxetine Tablet Treatment and Selective

Not yet recruiting
  • Major Depressive Disorder
  • Vortioxetine Tablet
  • SSRI
  • (no location specified)
Jun 28, 2023

Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • aiTBS
  • +2 more
  • Ghent, East-Flanders, Belgium
    University Hospital Ghent
Dec 6, 2022

Risk Factors for AD-Associated Switch to Mania

Completed
  • Bipolar Disorder
  • Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
  • Barcelona, Catalonia, Spain
    Hospital Clinic Barcelona
Nov 17, 2021

SSRI's and the Rate of Progression From MCI to Dementia

Recruiting
  • Mild Cognitive Impairment
  • +2 more
  • Columbus, Ohio
    The Ohio State University
Sep 8, 2021

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)

Recruiting
  • Depressive Disorder, Major
  • San Diego, California
  • +26 more
Aug 17, 2022

Major Depressive Disorder Who Have HadInadequate Response

Terminated
  • Depressive Disorder, Major
  • Standard of Care (SOC)
  • San Francisco, California
  • +3 more
Dec 6, 2022

Selective Serotonin Reuptake Inhibitor on Cognition, Sexual

Recruiting
  • Menopause
  • Hormone replacement therapy
  • Selective serotonin reuptake inhibitors
  • São Bernardo do Campo, SP, Brazil
    Centro de Atenção Integral à Saúde da Mulher
Jan 20, 2022

Stroke Trial in Bordeaux, Toulouse (Fluoxetine, Placebo, fMRI)

Unknown status
  • Stroke
  • Bordeaux, France
  • +1 more
Jul 29, 2020

Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Completed
  • Depressive Disorder, Major
  • Esketamine 28 mg
  • +6 more
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +170 more
Sep 13, 2022

Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

Not yet recruiting
  • Hypercapnia
  • Ventilatory Depression
  • Placebo and Oxycodone
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jul 20, 2022

Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of

Withdrawn
  • Stroke, Ischemic
  • Administration of SSRI escitalopram
  • +2 more
  • White Plains, New York
    Burke Neurological Institute
Jul 19, 2021

Fibromyalgia, Depression Trial in Dokki (Physiotherapy protocol, Selective serotonin reuptake inhibitors (SSRI))

Not yet recruiting
  • Fibromyalgia
  • Depression
  • Physiotherapy protocol
  • Selective serotonin reuptake inhibitors (SSRI)
  • Dokki, Egypt
    Outpatient clinic faculty of physica therapy cairo university
Mar 24, 2023

Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

Not yet recruiting
  • Depression
  • Serotonin Deficiency
  • Pharmacological agent: Citalopram
  • Placebo
  • Kelowna, British Columbia, Canada
    University of British Columbia, Okanagan Campus
Jul 19, 2023

Obesity, Depression Trial in Lucerne (Roux-en-Y gastric bypass, sleeve gastrectomy)

Completed
  • Obesity
  • Depression
  • Roux-en-Y gastric bypass, sleeve gastrectomy
  • Lucerne, Switzerland
    Luzerner Kantonsspital
Jun 9, 2021

Bipolar Disorder, Major Depression Trial in Cleveland (Selective Serotonin Reuptake Inhibitor (SSRI))

Completed
  • Bipolar Disorder
  • Major Depression
  • Selective Serotonin Reuptake Inhibitor (SSRI)
  • Cleveland, Ohio
    Cleveland Clinic Foundation Center for Behavioral Health
Nov 26, 2019

OCD Trial in Dhaka (N-acetylcysteine tablet 600mg, Placebo tablet 600mg)

Recruiting
  • OCD
  • N-acetylcysteine tablet 600mg
  • Placebo tablet 600mg
  • Dhaka, Bangladesh
  • +1 more
Nov 14, 2021

Depressive Disorder, Major Trial in Worldwide (Esketamine, SSRI/SNRI)

Active, not recruiting
  • Depressive Disorder, Major
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +58 more
Jan 31, 2023

Retinal Nerve Fiber Layer in First Episode Depressive Patients

Enrolling by invitation
  • Unipolar Depression
    • Diyarbakır, Turkey
      Sağlık Bilimleri Üniversitesi Gazi Yaşargil Tranining and Resear
    Mar 16, 2021

    MDD Trial in Hangzhou (SSRI, SIA, AIA)

    Recruiting
    • Major Depressive Disorder
    • Hangzhou, Zhejiang, China
      the Third affiliated hospital of Zhejiang Chinese Medical univer
    Jan 31, 2023

    Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin

    Withdrawn
    • Tracheostomy Complication
      • Columbus, Ohio
      • +1 more
      Nov 2, 2021

      MDD Trial in Hangzhou (SSRI, SIA, AIA)

      Recruiting
      • Major Depressive Disorder
      • Hangzhou, Zhejiang, China
        the Third affiliated hospital of Zhejiang Chinese Medical univer
      Apr 15, 2023

      MDD Trial in Dhaka (Magnesium Glycinate tablet 200mg, Placebo tablet 200mg)

      Completed
      • MDD
      • Magnesium Glycinate tablet 200mg
      • Placebo tablet 200mg
      • Dhaka, Bangladesh
        Basic Science and Paraclinical Science of BSMMU
      Mar 6, 2022

      Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)

      Not yet recruiting
      • Depression in Old Age
      • Fragility Fracture
      • Duloxetine 30 mg
      • Winston-Salem, North Carolina
        Wake Forest University Health Sciences
      May 9, 2023